Seven Eight Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,538
| Closed | -$73.3K | – | 851 |
|
|
2024
Q1 | $73.3K | Sell |
19,538
-250,629
| -93% | -$940K | 0.01% | 581 |
|
|
2023
Q4 | $2.65M | Buy |
270,167
+28,911
| +12% | +$284K | 0.31% | 79 |
|
|
2023
Q3 | $2.01M | Buy |
241,256
+221,353
| +1,112% | +$1.85M | 0.24% | 112 |
|
|
2023
Q2 | $265K | Sell |
19,903
-48,648
| -71% | -$647K | 0.04% | 418 |
|
|
2023
Q1 | $794K | Buy |
+68,551
| New | +$794K | 0.17% | 168 |
|
|
2022
Q4 | – | Sell |
-47,806
| Closed | -$278K | – | 574 |
|
|
2022
Q3 | $278K | Buy |
+47,806
| New | +$278K | 0.06% | 397 |
|
|
2022
Q2 | – | Sell |
-157,308
| Closed | -$1.43M | – | 561 |
|
|
2022
Q1 | $1.43M | Buy |
157,308
+73,819
| +88% | +$672K | 0.19% | 164 |
|
|
2021
Q4 | $1.71M | Buy |
+83,489
| New | +$1.71M | 0.31% | 103 |
|
|
2020
Q4 | – | Sell |
-20,000
| Closed | -$197K | – | 572 |
|
|
2020
Q3 | $197K | Buy |
+20,000
| New | +$197K | 0.04% | 522 |
|